Related Experiment Video
Updated: Jun 15, 2025

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
Published on: March 1, 2024
Age at diagnosis as a prognostic factor in selected categories of juvenile idiopathic arthritis
Anna-Kaisa Tuomi1,2, Katariina Rebane3,2, Ellen Arnstad4,5
1New Children's Hospital, Pediatric Research Center, HUS Helsinki University Hospital, Helsinki, Uusimaa, Finland tuomi.annakaisa@gmail.com.
Insights
Early diagnosis of juvenile idiopathic arthritis (JIA) impacts long-term remission. Younger age at diagnosis improved remission in oligoarthritis but not all seronegative polyarthritis cases, especially for females.
Area of Science:
- Pediatrics
- Rheumatology
- Clinical Immunology
Background:
- Juvenile idiopathic arthritis (JIA) onset age influences disease course.
- Understanding age-related remission predictors is crucial for JIA management.
Purpose of the Study:
- To determine how age at diagnosis affects long-term remission in JIA.
- To analyze age as a continuous variable in JIA remission prediction.
Main Methods:
- 358 patients from the Nordic JIA cohort study were analyzed.
- Age at diagnosis was assessed continuously and in age groups (<3, 3-5, >6 years).
- Data included disease activity, uveitis, labs, medication at 6 months, with outcomes at 17.5 years.
Main Results:
- Age at diagnosis predicted remission in oligoarthritis and seronegative polyarthritis.
- Earlier diagnosis (<3 years) showed higher remission in oligoarthritis, but not in all female seronegative polyarthritis patients.
- Age at diagnosis did not significantly impact HRQoL or functional ability.
Conclusions:
- Age at diagnosis is inversely associated with long-term remission in oligoarthritis JIA.
- Age at diagnosis is positively associated with long-term remission in seronegative polyarthritis JIA, particularly in females.
Introduction:
The age at the onset of juvenile idiopathic arthritis (JIA) can influence the trajectory of the disease. We aimed to clarify how age at the visit 6 months after the onset as a continuous variable affects long-term remission of JIA.
Methods:
This study investigated 358 patients from the Nordic JIA cohort study. Age at diagnosis was analysed continuously. Three age groups were studied: under 3 years, 3-5 years and over 6 years of age. JIA was categorised as oligoarthritis, seronegative polyarthritis and others (enthesitis-related, psoriatic and undifferentiated arthritis). Clinical data, collected at 6 months after the onset of symptoms, included information about disease activity, uveitis, laboratory test values and medication. The outcomes assessed 17.5 years after diagnosis included remission, health-related quality of life (HRQoL), and functional ability.
Results:
The majority of patients with oligoarthritis and polyarthritis were diagnosed before age six, compared with 29% in the group of others. In the oligoarthritis group, predictors of remission included age at diagnosis, male gender, the Juvenile Arthritis Disease Activity Score-71 (JADAS71) and the absence of uveitis. In seronegative polyarthritis, predictors of remission were age at diagnosis and JADAS71 score. In the oligoarthritis group, remission rates were highest in both genders when diagnosed <3 years of age. In the seronegative polyarthritis group, this was not true for female patients. Age at diagnosis had no significant effect on HRQoL or functional ability.
Conclusions:
Age at diagnosis in the oligoarthritis was inversely and in the seronegative polyarthritis positively associated with long-term remission in JIA, primarily in females.
Related Concept Videos
The JAK-STAT Signaling Pathway
Factors Affecting Illness
For instance, risk factors are connected to illness,...
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...

